FAPEX:用于鲁棒跨受试者癫痫预测的分数阶幅度-相位表达器
FAPEX: Fractional Amplitude-Phase Expressor for Robust Cross-Subject Seizure Prediction
AI总结:
针对受试者无关癫痫预测的频谱变异性挑战,提出FAPEX架构,通过引入可学习的分数阶神经框架算子结合状态空间建模与逐通道注意力,在12个跨物种和模态的基准上显著优于多种基线,实现了卓越的跨域泛化性能。
摘要:
由于个体和记录模态之间电生理信号固有的复杂性和显著的频谱变异性,精确、可泛化的受试者无关癫痫预测(SASP)仍然是一项根本挑战。我们提出了FAPEX,这是一种新颖的架构,它引入了可学习的分数阶神经框架算子(FrNFO)用于自适应时频分解。与对低频表现出频谱偏置的传统模型不同,我们的FrNFO采用分数阶卷积来捕获高频和低频动态,在最先进的基线上F1分数和灵敏度提高了约10%。FrNFO能够提取对发作前生物标志物发现特别有信息量的瞬时相位和幅度表示,并增强分布外泛化能力。FAPEX进一步集成了结构化状态空间建模和逐通道注意力机制,使其能够处理异构电极导联组合。在跨越物种(人类、大鼠、犬、猕猴)和模态(Scalp-EEG、SEEG、ECoG、LFP)的12个基准上进行评估,FAPEX在嵌套交叉验证下始终优于23个有监督和10个自监督基线,在复杂的跨域场景中灵敏度提升高达15%。它还在多个外部验证队列中进一步展现出卓越性能。据我们所知,这些结果确立了FAPEX作为首个在SASP中表现出持续优越性的癫痫模型,为发现支持存在独特且可识别的发作前状态的癫痫生物标志物证据及临床转化提供了一个有前景的解决方案。
英文摘要:
Precise, generalizable subject-agnostic seizure prediction (SASP) remains a fundamental challenge due to the intrinsic complexity and significant spectral variability of electrophysiological signals across individuals and recording modalities. We propose FAPEX, a novel architecture that introduces a learnable fractional neural frame operator (FrNFO) for adaptive time-frequency decomposition. Unlike conventional models that exhibit spectral bias toward low frequencies, our FrNFO employs fractional-order convolutions to capture both high and low-frequency dynamics, achieving approximately 10% improvement in F1-score and sensitivity over state-of-the-art baselines. The FrNFO enables the extraction of instantaneous phase and amplitude representations that are particularly informative for preictal biomarker discovery and enhance out-of-distribution generalization. FAPEX further integrates structural state-space modeling and channelwise attention, allowing it to handle heterogeneous electrode montages. Evaluated across 12 benchmarks spanning species (human, rat, dog, macaque) and modalities (Scalp-EEG, SEEG, ECoG, LFP), FAPEX consistently outperforms 23 supervised and 10 self-supervised baselines under nested cross-validation, with gains of up to 15% in sensitivity on complex cross-domain scenarios. It further demonstrates superior performance in several external validation cohorts. To our knowledge, these establish FAPEX as the first epilepsy model to show consistent superiority in SASP, offering a promising solution for discovering epileptic biomarker evidence supporting the existence of a distinct and identifiable preictal state and clinical translation.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。